{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:41:52Z","timestamp":1762540912816,"version":"3.41.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Pre-eclampsia constitutes a pregnancy disease characterized by hypertension and proteinuria, as well as dysregulation of the coagulation cascade and hypo fibrinolysis that affects many systems. The purpose of this study is to examine the connection between (-657 4G\/5G PAI-1) and the danger of preeclampsia in Egyptian females. A case-control study included 140 Egyptian pregnant women with PE along with 100 normotensive women. The study includes extracting genomic DNA from blood, detecting SNP with ARMS-PCR, and assessing metabolic parameters with serum samples. The study discovered significant variations in PAI-1 5G\/4G polymorphism between sufferers and the control group in general (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), dominant (<jats:italic>P<\/jats:italic>\u2009=\u20090.004), and recessive models (<jats:italic>P<\/jats:italic>\u2009=\u20090.009). Pre-eclamptic women had lower SOD activity and GSH levels but higher MDA and GPx activities than the normotensive pregnant group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study indicated that the \u2212\u2009657 4G\/5G PAI-I mutation is substantially linked to the development of PE in Egyptian women.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-025-07737-3","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:17:42Z","timestamp":1748251062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between PAI-1 gene \u2212\u2009657 4G\/5G polymorphism and preeclampsia in Egyptian women: a case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Omali Y.","family":"El-khawaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf M.","family":"ElSaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwyda","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliaa N.","family":"El-Daw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend A.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed F.","family":"Al-azzawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar","family":"refaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"issue":"9","key":"7737_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1161\/HYPERTENSIONAHA.122.18996","volume":"79","author":"A Kivioja","year":"2022","unstructured":"Kivioja A, et al. Increased risk of preeclampsia in women with a genetic predisposition to elevated blood pressure. Hypertension. 2022;79(9):2008\u201315.","journal-title":"Hypertension"},{"key":"7737_CR2","unstructured":"American JR. Immunol\u2013\u20092014 - Chen - Association between plasminogen activator Inhibitor-1 gene polymorphisms and.pdf."},{"key":"7737_CR3","doi-asserted-by":"crossref","unstructured":"Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the united States. Obstet Gynecol, 2009;113(6).","DOI":"10.1097\/AOG.0b013e3181a45b25"},{"issue":"5","key":"7737_CR4","doi-asserted-by":"publisher","first-page":"E218401","DOI":"10.1001\/jamanetworkopen.2021.8401","volume":"4","author":"Y Yang","year":"2021","unstructured":"Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. InPreeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and Cha. JAMA Netw Open. 2021;4(5):E218401. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.8401","journal-title":"JAMA Netw Open"},{"key":"7737_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","volume":"13","author":"MA Brown","year":"2018","unstructured":"Brown MA, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291\u2013310. https:\/\/doi.org\/10.1016\/j.preghy.2018.05.004","journal-title":"Pregnancy Hypertens"},{"key":"7737_CR6","doi-asserted-by":"publisher","unstructured":"Chang KJ, Seow KM, Chen KH. Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal Life-Threatening condition. Int J Environ Res Public Health. 2023;20(4). https:\/\/doi.org\/10.3390\/ijerph20042994","DOI":"10.3390\/ijerph20042994"},{"issue":"08","key":"7737_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1055\/s-0038-1675205","volume":"36","author":"I Mari\u0107","year":"2019","unstructured":"Mari\u0107 I, et al. Maternal height and risk of preeclampsia among Race\/ethnic groups. Am J Perinatol. 2019;36(08):864\u201371.","journal-title":"Am J Perinatol"},{"key":"7737_CR8","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1007\/s10995-016-1984-2","volume":"20","author":"K Nakagawa","year":"2016","unstructured":"Nakagawa K, Lim E, Harvey S, Miyamura J, Juarez DT. Racial\/ethnic disparities in the association between preeclampsia risk factors and preeclampsia among women residing in Hawaii. Matern Child Health J. 2016;20:1814\u201324.","journal-title":"Matern Child Health J"},{"issue":"3","key":"7737_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11906-017-0718-1","volume":"19","author":"RJ Waken","year":"2017","unstructured":"Waken RJ, de las Fuentes L, Rao DC. A review of the genetics of hypertension with a focus on Gene-Environment interactions. Curr Hypertens Rep. 2017;19(3):23. https:\/\/doi.org\/10.1007\/s11906-017-0718-1","journal-title":"Curr Hypertens Rep"},{"key":"7737_CR10","doi-asserted-by":"publisher","unstructured":"Galaviz-Hernandez C, Sosa-Macias M, Teran E, Garcia-Ortiz JE, Lazalde-Ramos BP. Paternal determinants in preeclampsia, Front Physiol, vol. 10, no. JAN, pp. 1\u20137, 2019, https:\/\/doi.org\/10.3389\/fphys.2018.01870","DOI":"10.3389\/fphys.2018.01870"},{"key":"7737_CR11","doi-asserted-by":"publisher","unstructured":"Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of Familial aggregation of preeclampsia: A population-based Swedish cohort study. Am J Med Genet A. Nov. 2004;130A(4):365\u201371. https:\/\/doi.org\/10.1002\/ajmg.a.30257","DOI":"10.1002\/ajmg.a.30257"},{"issue":"5","key":"7737_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/15513815.2019.1655819","volume":"39","author":"M Azimi-Nezhad","year":"2020","unstructured":"Azimi-Nezhad M, Teymoori A, Salmaninejad A, Ebrahimzadeh-Vesal R. Association of MTHFR C677T polymorphism with preeclampsia in North East of Iran (Khorasan Province). Fetal Pediatr Pathol. 2020;39(5):373\u201380. https:\/\/doi.org\/10.1080\/15513815.2019.1655819","journal-title":"Fetal Pediatr Pathol"},{"key":"7737_CR13","doi-asserted-by":"publisher","unstructured":"Zhao L, Bracken MB, DeWan AT, Chen S. Association between the SERPINE1 (PAI-1) 4G\/5G insertion\/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis, Mol Hum Reprod, vol. 19, no. 3, pp. 136\u2013143, Mar. 2013, https:\/\/doi.org\/10.1093\/molehr\/gas056","DOI":"10.1093\/molehr\/gas056"},{"issue":"1","key":"7737_CR14","first-page":"44","volume":"97","author":"CJ Glueck","year":"2001","unstructured":"Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol. 2001;97(1):44\u20138.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"7737_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/meta.2000.6749","volume":"49","author":"CJ Glueck","year":"2000","unstructured":"Glueck CJ, et al. The 4G\/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism-Clinical Experimental. 2000;49(7):845\u201352.","journal-title":"Metabolism-Clinical Experimental"},{"key":"7737_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-019-0018-1","volume":"20","author":"FA Khalaf","year":"2019","unstructured":"Khalaf FA, et al. Plasminogen activator inhibitor-1 gene polymorphism as a risk factor for vascular complications in type 2 diabetes mellitus. Egypt J Med Hum Genet. 2019;20:1\u201313.","journal-title":"Egypt J Med Hum Genet"},{"issue":"1","key":"7737_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13098-022-00900-2","volume":"14","author":"GES Batiha","year":"2022","unstructured":"Batiha GES, et al. Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship. Diabetol Metab Syndr. 2022;14(1):4\u20139. https:\/\/doi.org\/10.1186\/s13098-022-00900-2","journal-title":"Diabetol Metab Syndr"},{"key":"7737_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-981-10-5891-2_2","volume-title":"Genetic background of preeclampsia BT - preeclampsia: basic, genomic, and clinical","author":"J Sugawara","year":"2018","unstructured":"Sugawara J, Oe Y, Wagata M. In: Saito S, editor. Genetic background of preeclampsia BT - preeclampsia: basic, genomic, and clinical. Singapore: Springer Singapore; 2018. pp. 29\u201343. https:\/\/doi.org\/10.1007\/978-981-10-5891-2_2"},{"issue":"2","key":"7737_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0030-1270334","volume":"37","author":"AV D\u2019Elia","year":"2011","unstructured":"D\u2019Elia AV, Fabbro D, Driul L, Barillari G, Marchesoni D, Damante G. Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia. Semin Thromb Hemost. 2011;37(2):97\u2013105. https:\/\/doi.org\/10.1055\/s-0030-1270334","journal-title":"Semin Thromb Hemost"},{"key":"7737_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s40200-021-00839-7","volume":"20","author":"S Miri","year":"2021","unstructured":"Miri S, Sheikhha MH, Dastgheib SA, Shaker SA, Neamatzadeh H. Association of ACE I\/D and PAI-1 4G\/5G polymorphisms with susceptibility to type 2 diabetes mellitus. J Diabetes Metab Disord. 2021;20:1191\u20137.","journal-title":"J Diabetes Metab Disord"},{"issue":"6","key":"7737_CR21","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1530\/eje.0.1500793","volume":"150","author":"E Diamanti-Kandarakis","year":"2004","unstructured":"Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol. 2004;150(6):793\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"7737_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1055\/s-0037-1616045","volume":"86","author":"MT Sartori","year":"2001","unstructured":"Sartori MT, et al. Role of the 4G\/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients. Thromb Haemost. 2001;86(11):1161\u20139.","journal-title":"Thromb Haemost"},{"key":"7737_CR23","unstructured":"Jannes J. Polygenic disease: a study of genetic risk in an Australian stroke population. the Adelaide Genetic Stroke Study; 2004."},{"issue":"1","key":"7737_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1570-0232(02)00273-8","volume":"775","author":"R Agarwal","year":"2002","unstructured":"Agarwal R, Chase SD. Rapid, fluorimetric\u2013liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B. 2002;775(1):121\u20136. https:\/\/doi.org\/10.1016\/S1570-0232(02)00273-8","journal-title":"J Chromatogr B"},{"issue":"2","key":"7737_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0006-291X(72)80218-3","volume":"46","author":"M Nishikimi","year":"1972","unstructured":"Nishikimi M, Rao NA, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun. 1972;46(2):849\u201354.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"7737_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1182\/blood.V21.5.573.573","volume":"21","author":"E Beutler","year":"1963","unstructured":"Beutler E, Mary KYY. Erythrocyte glutathione reductase. Blood. 1963;21(5):573\u201385.","journal-title":"Blood"},{"issue":"1","key":"7737_CR27","first-page":"158","volume":"70","author":"DE Paglia","year":"1967","unstructured":"Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158\u201369.","journal-title":"J Lab Clin Med"},{"issue":"2","key":"7737_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1517\/14622416.1.2.231","volume":"1","author":"P-Y Kwok","year":"2000","unstructured":"Kwok P-Y. Approaches to allele frequency determination. Pharmacogenomics. 2000;1(2):231\u20135.","journal-title":"Pharmacogenomics"},{"issue":"4","key":"7737_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/jcmm.12751","volume":"20","author":"F Zhao","year":"2016","unstructured":"Zhao F, Song M, Wang Y, Wang W. Genetic model. J Cell Mol Med. 2016;20(4):765. https:\/\/doi.org\/10.1111\/jcmm.12751","journal-title":"J Cell Mol Med"},{"key":"7737_CR30","doi-asserted-by":"publisher","unstructured":"Morgan JA, Bombell S, McGuire W. Association of plasminogen activator Inhibitor-Type 1 (-675 4G\/5G) polymorphism with Pre-Eclampsia: systematic review. PLoS ONE. 2013;8(2). https:\/\/doi.org\/10.1371\/journal.pone.0056907","DOI":"10.1371\/journal.pone.0056907"},{"issue":"2","key":"7737_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/jwh.2020.8860","volume":"30","author":"R Correa-De-Araujo","year":"2021","unstructured":"Correa-De-Araujo R, Yoon SS. Clinical outcomes in High-Risk pregnancies due to advanced maternal age. J Womens Health. 2021;30(2):160\u20137. https:\/\/doi.org\/10.1089\/jwh.2020.8860","journal-title":"J Womens Health"},{"issue":"1","key":"7737_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-29889-3","volume":"8","author":"D Shan","year":"2018","unstructured":"Shan D, et al. Pregnancy outcomes in women of advanced maternal age: a retrospective cohort study from China. Sci Rep. 2018;8(1):1\u20139.","journal-title":"Sci Rep"},{"key":"7737_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.preghy.2019.09.009","volume":"18","author":"L Jieyu","year":"2019","unstructured":"Jieyu L, et al. Visit-to-visit blood pressure variability is associated with gestational hypertension and pre-eclampsia. Pregnancy Hypertens. 2019;18:126\u201331.","journal-title":"Pregnancy Hypertens"},{"issue":"9","key":"7737_CR34","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s41371-021-00580-x","volume":"36","author":"M Tadic","year":"2022","unstructured":"Tadic M, et al. Blood pressure variability correlates with right ventricular strain in women with gestational hypertension and preeclampsia. J Hum Hypertens. 2022;36(9):826\u201332.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"7737_CR35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1538-7836.2005.01226.x","volume":"3","author":"A Gerhardt","year":"2005","unstructured":"Gerhardt A, et al. The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI\u20101) 5G\/5G genotype are associated with early onset of severe preeclampsia. J Thromb Haemost. 2005;3(4):686\u201391.","journal-title":"J Thromb Haemost"},{"key":"7737_CR36","doi-asserted-by":"publisher","unstructured":"Francis CW. Plasminogen Activator Inhibitor-1 Levels and Polymorphisms: Association With Venous Thromboembolism, Arch Pathol Lab Med, vol. 126, no. 11, pp. 1401\u20131404, Nov. 2002, https:\/\/doi.org\/10.5858\/2002-126-1401-PAILAP","DOI":"10.5858\/2002-126-1401-PAILAP"},{"key":"7737_CR37","unstructured":"Gokhale-Agashe DS. Identification of Pre-eclampsia susceptibility genes, 2018."},{"issue":"4","key":"7737_CR38","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","volume":"213","author":"SJ Fisher","year":"2015","unstructured":"Fisher SJ. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol. 2015;213(4):S115\u201322.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7737_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/humupd\/dmw004","volume":"22","author":"F Schatz","year":"2016","unstructured":"Schatz F, Guzeloglu-Kayisli O, Arlier S, Kayisli UA, Lockwood CJ. The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update. 2016;22(4):497\u2013515.","journal-title":"Hum Reprod Update"},{"key":"7737_CR40","doi-asserted-by":"crossref","unstructured":"C. J. Lockwood, G. Krikun, M. Rahman, R. Caze, L. Buchwalder, and F. Schatz, The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states, in Seminars in thrombosis and hemostasis, Copyright\u00a9 2007 by Thieme Publishers, Inc., 333 Seventh Avenue, New York, NY\u2026 pp.111\u2013117.","DOI":"10.1055\/s-2006-958469"},{"key":"7737_CR41","doi-asserted-by":"crossref","unstructured":"M\u00fctze S, Rudnik-Sch\u00f6neborn S, Zerres K, Rath W. Genes and the preeclampsia syndrome, 2008.","DOI":"10.1515\/JPM.2008.004"},{"issue":"6","key":"7737_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00404-005-0117-8","volume":"273","author":"V Wiwanitkit","year":"2006","unstructured":"Wiwanitkit V. Correlation between plasminogen activator inhibitor-1 4G\/5G polymorphism and pre-eclampsia: an appraisal. Arch Gynecol Obstet. 2006;273(6):322\u20134. https:\/\/doi.org\/10.1007\/s00404-005-0117-8","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"7737_CR43","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/j.1538-7836.2004.00861.x","volume":"2","author":"MPM De Maat","year":"2004","unstructured":"De Maat MPM, et al. Preeclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost. 2004;2(9):1588\u201393.","journal-title":"J Thromb Haemost"},{"issue":"01","key":"7737_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1055\/s-0039-1694794","volume":"37","author":"J-J Sheen","year":"2020","unstructured":"Sheen J-J, et al. Maternal age and preeclampsia outcomes during delivery hospitalizations. Am J Perinatol. 2020;37(01):44\u201352.","journal-title":"Am J Perinatol"},{"key":"7737_CR45","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10389-017-0825-0","volume":"25","author":"ANQ Al-Tairi","year":"2017","unstructured":"Al-Tairi ANQ, Isa ZM, Ghazi HF. Risk factors of preeclampsia: a case control study among mothers in Sana\u2019a, Yemen. J Public Health (Bangkok). 2017;25:573\u201380.","journal-title":"J Public Health (Bangkok)"},{"key":"7737_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-015-0502-7","volume":"15","author":"GA Tessema","year":"2015","unstructured":"Tessema GA, Tekeste A, Ayele TA. Preeclampsia and associated factors among pregnant women attending antenatal care in Dessie referral hospital, Northeast Ethiopia: a hospital-based study. BMC Pregnancy Childbirth. 2015;15:1\u20137.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7737_CR47","doi-asserted-by":"crossref","unstructured":"Khader YS, Alyahya MS, Al-Sheyab NA, Shattnawi KK, Saqer HR, Batieha A. Evaluation of maternal and newborn health services in Jordan. J Multidiscip Healthc, 2018;439\u201356.","DOI":"10.2147\/JMDH.S171982"},{"issue":"9","key":"7737_CR48","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1097\/HJH.0000000000001375","volume":"35","author":"H Peng","year":"2017","unstructured":"Peng H, et al. Relationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians: findings from the strong heart study. J Hypertens. 2017;35(9):1787\u201393.","journal-title":"J Hypertens"},{"issue":"3","key":"7737_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/hr.2016.126","volume":"40","author":"M Umesawa","year":"2017","unstructured":"Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213\u201320. https:\/\/doi.org\/10.1038\/hr.2016.126","journal-title":"Hypertens Res"},{"key":"7737_CR50","unstructured":"Vishwekar PS, Yadav RK, Gohel CB. Thrombocytopenia during pregnancy and its Outcome-A prospective study. J Krishna Inst Med Sci (JKIMSU), 2017;6(1)."},{"issue":"2","key":"7737_CR51","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3945\/ajcn.115.107896","volume":"103","author":"MM Rahman","year":"2016","unstructured":"Rahman MM, et al. Maternal anemia and risk of adverse birth and health outcomes in low-and middle-income countries: systematic review and meta-analysis. Am J Clin Nutr. 2016;103(2):495\u2013504.","journal-title":"Am J Clin Nutr"},{"key":"7737_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s13224-012-0257-2","volume":"63","author":"E Habas","year":"2013","unstructured":"Habas E, Rayani A, Ganterie R. Thrombocytopenia in hypertensive disease of pregnancy. J Obstet Gynecol India. 2013;63:96\u2013100.","journal-title":"J Obstet Gynecol India"},{"key":"7737_CR53","doi-asserted-by":"crossref","unstructured":"Karateke A, Kurt RK, Balo\u011flu A. Relation of platelet distribution width (PDW) and platelet Crit (PCT) to preeclampsia. Ginekol Pol, 2015;86(5).","DOI":"10.17772\/gp\/2425"},{"issue":"1","key":"7737_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/14767058.2019.1572737","volume":"34","author":"MO Alese","year":"2021","unstructured":"Alese MO, Moodley J, Naicker T. Preeclampsia and HELLP syndrome, the role of the liver. J Maternal-Fetal Neonatal Med. 2021;34(1):117\u201323.","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"7737_CR55","first-page":"1","volume":"7","author":"N Martell-Claros","year":"2020","unstructured":"Martell-Claros N. Hypoalbuminemia as a risk factor for preeclampsia in the pregnant hypertensive population. J Womens Health Gyn. 2020;7:1\u20138.","journal-title":"J Womens Health Gyn"},{"key":"7737_CR56","doi-asserted-by":"crossref","unstructured":"Mohamed Zakaria AM, Elmoez Ali Saad AA, Salem HS, Hassan. and A. M. Abdel Ghaffar Moustafa, association of hypoalbuminemia in preeclampsia with maternal and perinatal outcomes. Egypt J Hosp Med, 2024;95.","DOI":"10.21608\/ejhm.2024.350103"},{"issue":"11","key":"7737_CR57","first-page":"549","volume":"11","author":"C Pramana","year":"2020","unstructured":"Pramana C, et al. Maternal characteristics and perinatal outcomes in women with severe preeclampsia. Syst Rev Pharm. 2020;11(11):549\u201353.","journal-title":"Syst Rev Pharm"},{"issue":"8","key":"7737_CR58","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3923\/jms.2013.791.796","volume":"13","author":"WE Olooto","year":"2013","unstructured":"Olooto WE, Amballi AA, Mosuro AO, Adeleye AA, Banjo TA. Assessment of total protein, albumin, creatinine and aspartate transaminase level in toxemia of pregnancy. J Med Sci. 2013;13(8):791.","journal-title":"J Med Sci"},{"issue":"5","key":"7737_CR59","doi-asserted-by":"publisher","first-page":"e0178150","DOI":"10.1371\/journal.pone.0178150","volume":"12","author":"J Lee","year":"2017","unstructured":"Lee J, et al. Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy. PLoS ONE. 2017;12(5):e0178150.","journal-title":"PLoS ONE"},{"issue":"2","key":"7737_CR60","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/jcm10020348","volume":"10","author":"F Weschenfelder","year":"2021","unstructured":"Weschenfelder F, Hein F, Lehmann T, Schleu\u00dfner E, Groten T. Contributing factors to perinatal outcome in pregnancies with gestational diabetes\u2014what matters most? A retrospective analysis. J Clin Med. 2021;10(2):348.","journal-title":"J Clin Med"},{"issue":"2","key":"7737_CR61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1024\/0301-1526\/a000171","volume":"41","author":"AA Salmi","year":"2012","unstructured":"Salmi AA, Zaki NM, Zakaria R, Nor Aliza AG, Rasool AH. Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus. Vasa. 2012;41(2):96\u2013104.","journal-title":"Vasa"},{"issue":"6","key":"7737_CR62","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/1933719117698576","volume":"25","author":"F Bugatto","year":"2018","unstructured":"Bugatto F, et al. The influence of lipid and Proinflammatory status on maternal uterine blood flow in women with late onset gestational diabetes. Reproductive Sci. 2018;25(6):837\u201343.","journal-title":"Reproductive Sci"},{"key":"7737_CR63","doi-asserted-by":"crossref","unstructured":"Ten\u00f3rio MB, Ferreira RC, Moura FA, Bueno NB, de Oliveira ACM, Goulart MOF. Cross-talk between oxidative stress and inflammation in preeclampsia, Oxid Med Cell Longev, vol. 2019, no. 1, p. 8238727, 2019.","DOI":"10.1155\/2019\/8238727"},{"issue":"3","key":"7737_CR64","first-page":"68","volume":"3","author":"L De Lucca","year":"2015","unstructured":"De Lucca L, Gallarreta FMP, Gon\u00e7alves TdeL. Oxidative stress markers in pregnant women with preeclampsia. Am J Med Biol Res. 2015;3(3):68\u201373.","journal-title":"Am J Med Biol Res"},{"key":"7737_CR65","doi-asserted-by":"crossref","unstructured":"Surmiak P, Wojnarowicz O, Szymkowiak M. Malondialdehyde and Neutrophil Gelatinase-Associated Lipocalin as Markers of Oxidative Stress in Small for Gestational Age Newborns from Hypertensive and Preeclamptic Pregnancies, Biomed Res Int, vol. 2022, no. 1, p. 9246233, 2022.","DOI":"10.1155\/2022\/9246233"},{"issue":"16","key":"7737_CR66","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3109\/14767058.2014.974537","volume":"28","author":"S Roy","year":"2015","unstructured":"Roy S, Dhobale M, Dangat K, Mehendale S, Lalwani S, Joshi S. Differential oxidative stress levels in mothers with preeclampsia delivering male and female babies. J Maternal-Fetal Neonatal Med. 2015;28(16):1973\u201380.","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"7737_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.placenta.2022.12.009","volume":"132","author":"VAF Freire","year":"2023","unstructured":"Freire VAF, de Melo AD, de Lima Santos H, Barros-Pinheiro M. Evaluation of oxidative stress markers in subtypes of preeclampsia: A systematic review and meta-analysis. Placenta. 2023;132:55\u201367.","journal-title":"Placenta"},{"issue":"2","key":"7737_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/10641963.2015.1081226","volume":"38","author":"V D\u2019Souza","year":"2016","unstructured":"D\u2019Souza V, et al. Increased oxidative stress from early pregnancy in women who develop preeclampsia. Clin Exp Hypertens. 2016;38(2):225\u201332.","journal-title":"Clin Exp Hypertens"},{"issue":"18","key":"7737_CR69","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3109\/14767058.2015.1111333","volume":"29","author":"A Nikolic","year":"2016","unstructured":"Nikolic A, Cabarkapa V, Novakov Mikic A, Jakovljevi\u0107 A, Stosic Z. Ceruloplasmin and antioxidative enzymes in pre-eclampsia. J Maternal-Fetal Neonatal Med. 2016;29(18):2987\u201393.","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"7737_CR70","doi-asserted-by":"crossref","unstructured":"Dahabiyeh LA, Tooth D, Kurlak LO, Mistry HD, Pipkin FB, Barrett DA. A pilot study of alterations in oxidized angiotensinogen and antioxidants in pre-eclamptic pregnancy, Sci Rep, vol. 10, no. 1, p. 1956, 2020.","DOI":"10.1038\/s41598-020-58930-7"},{"issue":"6","key":"7737_CR71","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.tjog.2018.10.002","volume":"57","author":"A Taravati","year":"2018","unstructured":"Taravati A, Tohidi F. Comprehensive analysis of oxidative stress markers and antioxidants status in preeclampsia. Taiwan J Obstet Gynecol. 2018;57(6):779\u201390.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"7737_CR72","doi-asserted-by":"crossref","unstructured":"Schoenherr A, Norton C, Vadali M, Bryson A, Fay WP, Ji Y. Plasminogen activator inhibitor-1 (PAI-1) increases mitochondrial membrane potential in vascular smooth muscle cells and coronary arteries. Arterioscler Thromb Vasc Biol, 2023;43(Suppl_1):A659\u2013A659.","DOI":"10.1161\/atvb.43.suppl_1.659"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07737-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:17:52Z","timestamp":1748251072000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07737-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7737"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07737-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in accordance with the guidelines of the Declaration of Helsinki. The Ethical Committee of Mansoura University gave approval (date 10\/10\/2021 - No. R.21.09.1447). All participants provided informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from participants for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"610"}}